Fecal Calprotectin Assay at an Early Stage of Treatment Can Be Used as a Surrogate Marker to Predict Clinical Remission and Mucosal Healing in Pediatric Crohn's Disease
-
- Pediatric Gastroenterology, Hepatology & Nutrition
- /
- v.25 no.5
- /
- pp.396-405
- /
- 2022